AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,828.00p
   
  • Change Today:
    -48.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.68m
  • Volume: 69,334
  • Market Cap: £183,415m
  • RiskGrade: 123

Latest ShareCast News

London close: Stocks fall on Trump's latest tariffs, US jobs data

By Josh White

Date: Friday 01 Aug 2025

(Sharecast News) - London stocks ended the week lower on Friday as investors reacted to a fresh wave of US tariffs and disappointing economic data from the United States.

London close: Stocks mixed on corporate updates, trade developments

By Josh White

Date: Tuesday 29 Jul 2025

(Sharecast News) - London stocks ended Tuesday on a mixed note as a wave of corporate results kept investors busy and market participants continued to assess the implications of the recent US-EU trade deal.

Astrazeneca H1 gross profits up 10pc as 'strong growth momentum' continues

By Iain Gilbert

Date: Tuesday 29 Jul 2025

(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that "strong growth momentum" had continued in H1, with "excellent R&D pipeline delivery" in the year-to-date.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,828.00p
Change Today -48.00p
% Change -0.40 %
52 Week High 13,276.00p
52 Week Low 9,667.00p
Volume 69,334
Shares Issued 1,550.68m
Market Cap £183,415m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 28-Aug-2025

Time Volume / Share Price
09:30 34 @ 11,828.00p
09:30 0 @ 11,830.00p
09:30 4 @ 11,828.00p
09:30 29 @ 11,832.00p
09:30 152 @ 11,833.11p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page